Drug Profile
Research programme: Candida vaccines - Provalis/University of Newcastle
Alternative Names: MoniliastatLatest Information Update: 05 Feb 2008
Price :
$50
*
At a glance
- Originator Provalis; University of Newcastle, Australia
- Class Fungal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis